1. Home
  2. TSBX vs MYNZ Comparison

TSBX vs MYNZ Comparison

Compare TSBX & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSBX
  • MYNZ
  • Stock Information
  • Founded
  • TSBX 2015
  • MYNZ 2021
  • Country
  • TSBX United States
  • MYNZ Germany
  • Employees
  • TSBX N/A
  • MYNZ N/A
  • Industry
  • TSBX
  • MYNZ Biotechnology: Pharmaceutical Preparations
  • Sector
  • TSBX
  • MYNZ Health Care
  • Exchange
  • TSBX Nasdaq
  • MYNZ Nasdaq
  • Market Cap
  • TSBX 11.4M
  • MYNZ 11.2M
  • IPO Year
  • TSBX 2023
  • MYNZ 2021
  • Fundamental
  • Price
  • TSBX $0.48
  • MYNZ $6.53
  • Analyst Decision
  • TSBX Buy
  • MYNZ Hold
  • Analyst Count
  • TSBX 3
  • MYNZ 2
  • Target Price
  • TSBX $4.75
  • MYNZ N/A
  • AVG Volume (30 Days)
  • TSBX 93.1K
  • MYNZ 1.6M
  • Earning Date
  • TSBX 11-12-2024
  • MYNZ 10-21-2024
  • Dividend Yield
  • TSBX N/A
  • MYNZ N/A
  • EPS Growth
  • TSBX N/A
  • MYNZ N/A
  • EPS
  • TSBX N/A
  • MYNZ N/A
  • Revenue
  • TSBX N/A
  • MYNZ $917,203.00
  • Revenue This Year
  • TSBX N/A
  • MYNZ $21.95
  • Revenue Next Year
  • TSBX N/A
  • MYNZ $30.77
  • P/E Ratio
  • TSBX N/A
  • MYNZ N/A
  • Revenue Growth
  • TSBX N/A
  • MYNZ 16.23
  • 52 Week Low
  • TSBX $0.40
  • MYNZ $0.18
  • 52 Week High
  • TSBX $5.75
  • MYNZ $7.95
  • Technical
  • Relative Strength Index (RSI)
  • TSBX 39.58
  • MYNZ 59.79
  • Support Level
  • TSBX $0.48
  • MYNZ $3.65
  • Resistance Level
  • TSBX $0.51
  • MYNZ $7.95
  • Average True Range (ATR)
  • TSBX 0.05
  • MYNZ 0.95
  • MACD
  • TSBX -0.00
  • MYNZ -0.18
  • Stochastic Oscillator
  • TSBX 22.22
  • MYNZ 59.07

About TSBX Turnstone Biologics Corp.

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.

About MYNZ Mainz Biomed N.V.

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.

Share on Social Networks: